Protic, D.; Stojkovic, M.; Budimirovic, D. TARGETED DRUG DEVELOPMENT IN FRAGILE X SYNDROME: MOLECULAR MEDICINE AS A KEY TOOL IN CLINICAL PHARMACOLOGY. medi 2025, 59 (2). https://doi.org/10.5937/medi0-60213.